Is Lipid Based Formulation Best for Your Molecule? Insights from exclusive survey on strategies for poorly soluble molecules
Sponsored by: Catalent Pharma Solutions
- Lipid Based Technology
Date: 27 March
Time: 11AM New York/3PM London
Enhancing bioavailability has remained a top priority for drug development scientists, and increasingly so due to the complexity of molecules emerging from discovery. Lipid based formulation has a long history of commercial success, having enabled over 60 NDAs in the US alone.
Learn the key considerations for evaluating available technologies to find the most suitable bioavailability solution. When is lipid delivery perhaps the best option? An exclusive survey conducted with hundreds of front-line formulation scientists on their criteria for selecting bioavailability enhancing technologies will shed light on these questions.
Register for the webinar to hear the opinion of hundreds of respondents and insights of industry experts, with an opportunity to ask questions and share your own opinion. Recent innovations in lipid-based technology and case studies will also be discussed.
Panos Constantinides, Ph.D.,
President, Biopharmaceutical & Drug Delivery Consulting
Dr. Constantinides is President of Biopharmaceutical & Drug Delivery Consulting, LLC in Gurnee, Illinois, USA that he founded in 2004, and he has more than 30 years of industrial experience in drug delivery and pharmaceutical development. He received a University Diploma in Chemistry from Athens University in 1977 and PhD in Biochemistry from Brown University in 1983.
Over a time span of 30 years, he held multiple position in academia and industry. He is inventor in 33 patents and patent applications, has authored more than 50 publications including review articles, book chapters and commentaries on the parenteral, oral and topical delivery of small molecule drugs and peptide/protein therapeutics using lipid-based and other nanoparticulate systems. He has presented more than 100 invited talks at many national and international conferences, pharmaceutical companies, contract development and manufacturing organizations and academic institutions.
Dr. Constantinides is AAPS Fellow, Past Chair of the AAPS Formulation Design and Development (FDD) Section, the Nanotechnology and Lipid-Based Drug Delivery Systems Focus Groups. He has received numerous honors and awards and serves as Editor of the AAPS Open journal since its launch in the fall of 2015.
Ronak Savla, Pharm.D., Ph.D.,
Scientific Affairs Manager, Catalent Pharma Solutions
Ronak Savla, Pharm.D., Ph.D., is the Scientific Affairs Manager at Catalent Pharma Solutions and a Co-Chair of the Catalent Applied Drug Delivery Institute. Since taking on his current role in 2016, Dr. Savla is responsible for the strategy and execution of the scientific communications plan, management of external collaborations, identification and nurturing relationship with Key Opinion Leaders, scientific assessment of novel drug delivery technologies, oversight of internal technology development, and leadership of the Scientific Excellence Initiative. Prior to his current role, Dr. Savla was the Applied Drug Delivery Fellow at Catalent as part of the Rutgers Pharmaceutical Industry Fellowship program from 2014 to 2016. Dr. Savla obtained his Pharm.D. and Ph.D. degrees from Rutgers University.
Dr. Savla is an author on over 60 papers, articles, posters, and abstracts and has given dozens of conference presentations that cover a wide range of drug delivery topics. Dr. Savla was recently appointed to the Editorial Advisory Board of American Pharmaceutical Review.
Key Learning Objectives
- Understand the pros and cons of lipid-based formulation versus other bioavailability enhancing technologies
- Learn factors to consider when selecting the right formulation for your molecules at each phase
- Learn the truths and myths of lipid formulations that are perceived by scientists today
- Formulation scientist
- Senior Director/Director / R&D
- Senior Director/Director / Formulation
- Senior Director/Director / Translational Sciences
- Senior Director/Director / Manufacturing & Operations
- Vice President / CMC
- Senior Director/Director / CMC
- Senior Director/Director / Pharmaceutical Development